Implicit rationing in the physician-patient choice of lung cancer treatment
| dc.contributor.author | Arndt, Kevin Charles | en_US |
| dc.date.accessioned | 2024-08-12T19:31:01Z | |
| dc.date.available | 2024-08-12T19:31:01Z | |
| dc.date.copyright | 1994 | en_US |
| dc.date.issued | 1994 | |
| dc.degree.department | Department of Economics | |
| dc.degree.level | Master of Arts M.A. | en |
| dc.description.abstract | This study uses data collected from non-small cell lung cancer patients attending the Victoria Clinic of the British Columbia Cancer Agency to analyze implicit rationing in the physician-patient choice of lung cancer treatment. An ordered logit model is estimated to identify the impacts of disease states and personal attributes on the probability of a patient receiving alternative degrees of treatment aggressiveness. Logistic probability estimates for the various treatment strategies are linked to corresponding treatment costs, and expected cost-age profiles are calculated for an illustrative patient profile. Direct comparisons of expected cost-age profiles are conducted within a ceteris paribus framework to investigate implicit non-disease criteria in the rationing of lung cancer treatment. The results indicate that non-small cell lung cancer treatment is implicitly rationed according to several personal attributes of a patient. Main empirical results are: (a) Significant differences in expected costs are attributable to patient age, with progressively lower levels of treatment expenditures among older age categories; (b) Patients who have never been married sustain 48 percent to 68 percent less in expected treatment costs than patients who are widowed, divorced, or currently married; (c) Physician perceptions of patient health status, as revealed by the Karnofsky Performance Index, contribute to differences among expected treatment costs for patients assigned a rank of 100 or 90, a rank of 80, or a rank of 70 or less; (d) Expected costs of treatment do not significantly differ with respect to patient gender. The study concludes that high cost lung cancer treatments may already be rationed implicitly to a much greater degree than is generally assumed. | en |
| dc.format.extent | 133 pages | |
| dc.identifier.uri | https://hdl.handle.net/1828/16982 | |
| dc.rights | Available to the World Wide Web | en_US |
| dc.title | Implicit rationing in the physician-patient choice of lung cancer treatment | en_US |
| dc.type | Thesis | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ARNDT_Kevin_Charles_MA_1994_675240.pdf
- Size:
- 20.79 MB
- Format:
- Adobe Portable Document Format